
09.06.2025
New Global Collaboration for Investigational Drug
We have acquired exclusive rights to commercialise an investigational oral therapy for early-stage Alzheimer’s disease in our key markets, including...
We have acquired exclusive rights to commercialise an investigational oral therapy for early-stage Alzheimer’s disease in our key markets, including...
For the sixth consecutive year, Acino has achieved Level 1 Broad-Based Black Economic Empowerment (B-BBEE) contributor status in South Africa....
We are proud to share that Acino has been named one of Ukraine’s Top 50 Best Employers for the second...
We are delighted to announce that Acino South Africa has been recognised as a Top Employer for 2025, marking the...
Maryna Larionova joined Acino Ukraine as an Accountant in August 2017, during a transformative period in her life. As a...
Arcera aims to become a global life sciences company, with the purpose of enabling longer and healthier lives while driving...
With an impressive 23-year tenure, Mohammed Iqbal stands as a pillar of dedication at Acino. Beginning his remarkable journey with...
The Acino production site, Pharma Start, in Ukraine has successfully completed an EU GMP audit conducted by the State Agency...
Report underscores Acino’s continued commitment to Environmental, Social, and Governance goals, including a firm commitment to reaching full carbon neutrality...